Design Maps for the Hyperthermic Treatment of Tumors with Superparamagnetic Nanoparticles

PLoS ONE

Volumn 8, Issue 2, 2013, Pages

  Cervadoro, Antonio ^a,b   Giverso, Chiara ^b   Pande, Rohit ^c   Sarangi, Subhasis ^c   Preziosi, Luigi ^b   Wosik, Jarek ^c   Brazdeikis, Audrius ^c,d   Decuzzi, Paolo ^a,e  

^a HOUSTON METHODIST RESEARCH INSTITUTE   (United States)

^b POLITECNICO DI TORINO   (Italy)

^c UNIVERSITY OF HOUSTON   (United States)

^d University of Houston   (United States)

^e UNIVERSITY MAGNA GRAECIA OF CATANZARO   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

SUPERPARAMAGNETIC IRON OXIDE NANOPARTICLE;

ANALYTICAL PARAMETERS; ARTICLE; BIOACCUMULATION; CONCENTRATION (PARAMETERS); ELECTRIC CONDUCTIVITY; ENERGY RESOURCE; FREQUENCY MODULATION; HEATING; HYPERTHERMIC THERAPY; LINEAR SYSTEM; MAGNETIC FIELD; MATHEMATICAL COMPUTING; MATHEMATICAL MODEL; RADIOFREQUENCY ABLATION; SPECIFIC ABSORPTION RATE; TISSUE SECTION; TUMOR BLOOD FLOW;

HUMANS; HYPERTHERMIA, INDUCED; MAGNETICS; MICROSCOPY, ELECTRON, SCANNING; NANOPARTICLES; NEOPLASMS;

EID: 84874393739     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0057332     Document Type: Article

References (60)

1. Cherukuri P, Glazer ES, Curley SA, (2010) Targeted hyperthermia using metal nanoparticles. Adv Drug Deliv Rev 62: 339-345.
2. Manthe RL, Foy SP, Krishnamurthy N, Sharma B, Labhasetwar V, (2010) Tumor ablation and nanotechnology. Mol Pharm 7: 1880-1898.
3. Coss RA, Linnemans WA, (1996) The effects of hyperthermia on the cytoskeleton: a review. Int J Hyperthermia 12: 173-196.
4. Garcia MP, Cavalheiro JR, Fernandes MH, (2012) Acute and long-term effects of hyperthermia in B16-F10 melanoma cells. PLoS One 7: e35489.
5. Majda JA, Gerner EW, Vanlandingham B, Gehlsen KR, Cress AE, (1994) Heat shock-induced shedding of cell surface integrins in A549 human lung tumor cells in culture. Exp Cell Res 210: 46-51.
6. Huang SH, Yang KJ, Wu JC, Chang KJ, Wang SM, (1999) Effects of hyperthermia on the cytoskeleton and focal adhesion proteins in a human thyroid carcinoma cell line. J Cell Biochem 75: 327-337.
7. Hildebrandt B, Wust P, Ahlers O, Dieing A, Sreenivasa G, et al. (2002) The cellular and molecular basis of hyperthermia. Crit Rev Oncol Hematol 43: 33-56.
8. Coleman A, Augustine CK, Beasley G, Sanders G, Tyler D, (2009) Optimizing regional infusion treatment strategies for melanoma of the extremities. Expert Rev Anticancer Ther 9: 1599-1609.
9. van der Zee J, (2002) Heating the patient: a promising approach? Ann Oncol 13: 1173-1184.
10. Dewei J, Liu J, (2010) Current devices for high-performance whole-body hyperthermia therapy. Expert Rev Med Devices 7: 407-423.
11. Wust P, Hildebrandt B, Sreenivasa G, Rau B, Gellermann J, et al. (2002) Hyperthermia in combined treatment of cancer. Lancet Oncol 3: 487-497.
12. Rao W, Deng ZS, Liu J, (2010) A review of hyperthermia combined with radiotherapy/chemotherapy on malignant tumors. Crit Rev Biomed Eng 38: 101-116.
13. Hildebrandt B, Wust P, (2007) The biologic rationale of hyperthermia. Cancer Treat Res 134: 171-184.
14. Curley SA, (2003) Radiofrequency ablation of malignant liver tumors. Ann Surg Oncol 10: 338-347.
15. Arciero CA, Sigurdson ER, (2008) Diagnosis and treatment of metastatic disease to the liver. Semin Oncol 35: 147-159.
16. Shenoi MM, Anderson J, Bischof JC, (2009) Nanoparticle enhanced thermal therapies. Conf Proc IEEE Eng Med Biol Soc 2009: 1979-1982.
17. Lu W, Melancon MP, Xiong C, Huang Q, Elliott A, et al. (2011) Effects of photoacoustic imaging and photothermal ablation therapy mediated by targeted hollow gold nanospheres in an orthotopic mouse xenograft model of glioma. Cancer Res 71: 6116-6121.
18. O'Neal DP, Hirsch LR, Halas NJ, Payne JD, West JL, (2004) Photo-thermal tumor ablation in mice using near infrared-absorbing nanoparticles. Cancer Lett 209: 171-176.
19. von Maltzahn G, Park JH, Agrawal A, Bandaru NK, Das SK, et al. (2009) Computationally guided photothermal tumor therapy using long-circulating gold nanorod antennas. Cancer Res 69: 3892-3900.
20. Stern JM, Stanfield J, Kabbani W, Hsieh JT, Cadeddu JA, (2008) Selective prostate cancer thermal ablation with laser activated gold nanoshells. J Urol 179: 748-753.
21. Gobin AM, Watkins EM, Quevedo E, Colvin VL, West JL, (2010) Near-infrared-resonant gold/gold sulfide nanoparticles as a photothermal cancer therapeutic agent. Small 6: 745-752.
22. Stafford RJ, Shetty A, Elliott AM, Schwartz JA, Goodrich GP, et al. (2011) MR temperature imaging of nanoshell mediated laser ablation. Int J Hyperthermia 27: 782-790.
23. Shi Kam NW, (2005) Carbon nanotubes as multifunctional biological transporters and near-infrared agents for selective cancer cell destruction. Proceedings of the National Academy of Sciences 102: 11600-11605.
24. Gannon CJ, Cherukuri P, Yakobson BI, Cognet L, Kanzius JS, et al. (2007) Carbon nanotube-enhanced thermal destruction of cancer cells in a noninvasive radiofrequency field. Cancer 110: 2654-2665.
25. Lewinski N, Colvin V, Drezek R, (2008) Cytotoxicity of nanoparticles. Small 4: 26-49.
26. Rosensweig RE, (2002) Heating magnetic fluid with alternating magnetic field. J Magnetism Mag Mats 252: 370-374.
27. Bulte JW, Kraitchman DL, (2004) Iron oxide MR contrast agents for molecular and cellular imaging. NMR Biomed 17: 484-499.
28. Laurent S, Bridot JL, Elst LV, Muller RN, (2010) Magnetic iron oxide nanoparticles for biomedical applications. Future Med Chem 2: 427-449.
29. Pankhurst QA, Thanh NKT, Jones SK, Dobson J, (2009) Progress in applications of magnetic nanoparticles in biomedicine. Journal of Physics D: Applied Physics 42: 224001.
30. Levy M, Lagarde F, Maraloiu VA, Blanchin MG, Gendron F, et al. (2010) Degradability of superparamagnetic nanoparticles in a model of intracellular environment: follow-up of magnetic, structural and chemical properties. Nanotechnology 21: 395103.
31. Hergt R, Dutz S, Röder M, (2008) Effects of size distribution on hysteresis losses of magnetic nanoparticles for hyperthermia. Journal of Physics: Condensed Matter 20: 385214.
32. Kumar CSSR, Mohammad F, (2011) Magnetic nanomaterials for hyperthermia-based therapy and controlled drug delivery. Advanced Drug Delivery Reviews 63: 789-808.
33. Huber DL, (2005) Synthesis, properties, and applications of iron nanoparticles. Small 1: 482-501.
34. Laurent S, Dutz S, Häfeli UO, Mahmoudi M (2011) Magnetic fluid hyperthermia: Focus on superparamagnetic iron oxide nanoparticles. Advances in Colloid and Interface Science.
35. Kallumadil M, Tada M, Nakagawa T, Abe M, Southern P, et al. (2009) Suitability of commercial colloids for magnetic hyperthermia. Journal of Magnetism and Magnetic Materials 321: 1509-1513.
36. Fortin J-P, Wilhelm C, Servais J, Ménager C, Bacri JC, et al. (2007) Size-Sorted Anionic Iron Oxide Nanomagnets as Colloidal Mediators for Magnetic Hyperthermia. J AM CHEM SOC 129.
37. Elsherbini AAM, Saber M, Aggag M, El-Shahawy A, Shokier HAA, (2011) Magnetic nanoparticle-induced hyperthermia treatment under magnetic resonance imaging. Magnetic Resonance Imaging 29: 272-280.
38. Dennis CL, Jackson AJ, Borchers JA, Hoopes PJ, Strawbridge R, et al. (2009) Nearly complete regression of tumors via collective behavior of magnetic nanoparticles in hyperthermia. Nanotechnology 20: 395103.
39. Suzuki M, Shinkai M, Honda H, Kobayashi T, (2003) Anticancer effect and immune induction by hyperthermia of malignant melanoma using magnetite cationic liposomes. Melanoma Res 13: 129-135.
40. Pennes HH, (1998) Analysis of tissue and arterial blood temperatures in the resting human forearm. 1948. J Appl Physiol 85: 5-34.
41. Arkin H, Xu LX, Holmes KR, (1994) Recent developments in modeling heat transfer in blood perfused tissues. IEEE Trans Biomed Eng 41: 97-107.
42. Schutt DJ, Haemmerich D, (2008) Effects of variation in perfusion rates and of perfusion models in computational models of radio frequency tumor ablation. Med Phys 35: 3462-3470.
43. Gasselhuber A, Dreher MR, Negussie A, Wood BJ, Rattay F, et al. (2010) Mathematical spatio-temporal model of drug delivery from low temperature sensitive liposomes during radiofrequency tumour ablation. Int J Hyperthermia 26: 499-513.
44. Purushotham S, Ramanujan RV, (2010) Modeling the performance of magnetic nanoparticles in multimodal cancer therapy. Journal of Applied Physics 107: 114701.
45. Li Z, Kawashita M, Araki N, Mitsumori M, Hiraoka M, et al. (2010) Magnetite nanoparticles with high heating efficiencies for application in the hyperthermia of cancer. Materials Science and Engineering: C 30: 990-996.
46. Beković M, Hamler A, (2010) Determination of the Heating Effect of Magnetic Fluid in Alternating Magnetic Field. IEEE TRANSACTIONS ON MAGNETICS 46: 4.
47. Lobo SM, Afzal KS, Ahmed M, Kruskal JB, Lenkinski RE, et al. (2004) Radiofrequency Ablation- Modeling the Enhanced Temperature Response to Adjuvant NaCl Pretreatment. Radiology 230: 175-182.
48. Dennis CL, Jackson AJ, Borchers JA, Ivkov R, Foreman AR, et al. (2008) The influence of magnetic and physiological behaviour on the effectiveness of iron oxide nanoparticles for hyperthermia. Journal of Physics D: Applied Physics 41: 134020.
49. dos Santos I, Haemmerich D, Pinheiro C, da Rocha A, (2008) Effect of variable heat transfer coefficient on tissue temperature next to a large vessel during radiofrequency tumor ablation. BioMedical Engineering OnLine 7: 21.
50. Lee J-H, Jang J-t, Choi J-s, Moon SH, Noh S-h, et al. (2011) Exchange-coupled magnetic nanoparticles for efficient heat induction. Nature Nanotechnology 6: 418-422.
51. Bae KH, Park M, Do MJ, Lee N, Ryu JH, et al. (2012) Chitosan oligosaccharide-stabilized ferrimagnetic iron oxide nanocubes for magnetically modulated cancer hyperthermia. ACS Nano 6: 5266-5273.
52. Guardia P, Di Corato R, Lartigue L, Wilhelm C, Espinosa A, et al. (2012) Water-soluble iron oxide nanocubes with high values of specific absorption rate for cancer cell hyperthermia treatment. ACS Nano 6: 3080-3091.
53. Atkinson WJ, Brezovich IA, Chakraborty DP, (1984) Usable frequencies in hyperthermia with thermal seeds. IEEE Trans Biomed Eng 31: 70-75.
54. Crayton SH, Elias DR, Al Zaki A, Cheng Z, Tsourkas A, (2012) ICP-MS analysis of lanthanide-doped nanoparticles as a non-radiative, multiplex approach to quantify biodistribution and blood clearance. Biomaterials 33: 1509-1519.
55. van de Ven AL, Kim P, Haley O, Fakhoury JR, Adriani G, et al. (2012) Rapid tumoritropic accumulation of systemically injected plateloid particles and their biodistribution. J Control Release 158: 148-155.
56. Godin B, Chiappini C, Srinivasan S, Alexander JF, Yokoi K, et al. (2012) Discoidal Porous Silicon Particles: Fabrication and Biodistribution in Breast Cancer Bearing Mice. Advanced Functional Materials: 4225-4235.
57. Chertok B, Moffat BA, David AE, Yu F, Bergemann C, et al. (2008) Iron oxide nanoparticles as a drug delivery vehicle for MRI monitored magnetic targeting of brain tumors. Biomaterials 29: 487-496.
58. Heidsieck A, Vosen S, Zimmermann K, Wenzel D, Gleich B (2012) Analysis of Trajectories for Targeting of Magnetic Nanoparticles in Blood Vessels. Mol Pharm.
59. Li YF, Chen C, (2011) Fate and toxicity of metallic and metal-containing nanoparticles for biomedical applications. Small 7: 2965-2980.
60. Klausner RD, Rouault TA, Harford JB, (1993) Regulating the fate of mRNA: the control of cellular iron metabolism. Cell 72: 19-28.